Acurx is Setting a High Bar for New Treatments in C. diff
Stockwatch,
(via NewsDirect) A New Gold Standard for C. diff Therapy Could be in the Offing; Next Data Release Expected in 2Q23…
(via NewsDirect) A New Gold Standard for C. diff Therapy Could be in the Offing; Next Data Release Expected in 2Q23…
Clostridioides difficile/Clostridium difficile (C. diff) is a bacterial infection and is the most common cause of healthcare-asso…
Staten Island, NY News Direct Acurx Pharmaceuticals Inc A New Gold Standard for C.
Staten Island, NY --News Direct-- Acurx Pharmaceuticals Inc A New Gold Standard for C.